Coronary thrombolysis with recombinant tissue-type plasminogen activator: Patency rate and regional wall motion after 3 months
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 8 (6), 1455-1460
- https://doi.org/10.1016/s0735-1097(86)80323-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Human tissue-type plasminogen activator: from the laboratory to the bedside.Circulation, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Variability in the measurement of regional left ventricular wall motion from contrast angiograms.Circulation, 1983